600645.SH
中源协和
SSE · Healthcare · Biotechnology · CN
CNY 19.23
−3.99%Aug 18, 2026, 03:29 UTC
ACME Solar Holdings completed INR 21.47 billion in refinancing to redeem non-convertible debentures issued by 12 operational solar project SPVs with a combined capacity of 450MW, and fully redeemed its underlying offshore dollar bonds.
Source:Jul 30, 2026, 09:38 UTC
Zhongyuan Xiehe obtained a Class III medical device registration certificate in February 2026.
Source:Jul 17, 2026, 07:43 UTC
Zhongyuan Xiehe's subsidiary Wuhan Optics Valley Zhongyuan Pharmaceutical enrolled the first subject for multiple-dose administration in Phase I of the I/II clinical trial of VUM02 injection for acute graft-versus-host disease.
Source: